Search results

Safely collecting any biopsy sample from an internal organ is always a challenge; adding the need to make successive collections increases the difficulty.

Discover seven tips from expert toxicologist and consultant Robin Guy on tackling key challenges for in vitro NAMs studies, from data integrity to regulatory acceptance.

Toxicologist Mary Ellen Cosenza explains the FDA’s 2025 roadmap for phasing out animal testing and its implications for drug development and safety.